Precision Medicine
AI-powered prognosis test company Spotlight Medical secures €6.2m in seed funding
July 15, 2024Research and Development Oncology, Precision Medicine, Spotlight Medical, artificial intelligence, oncology, seed funding
Start-up Spotlight Medical has announced it has raised €6.2m in a seed funding round led by Kurma Partners and Heal Capital. …
Breakthrough announced in circulating tumour cell research
June 18, 2021Medical Communications Cancer, Circulating tumour cells, Precision Medicine, oncology
Liquid biopsy company, Angle, has announced results from their study in non-small cell lung cancer (NSCLC) which demonstrates the benefit …
University of Glasgow research details promising precision medicine approach in pancreatic cancer
October 12, 2020Research and Development, Sales and Marketing Cancer, Precision Medicine
Researchers at the University of Glasgow have unveiled a new precision medicine approach to identify and pair pancreatic cancer patients …
Collaborating to realise the potential of precision medicine
January 20, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Precision Medicine, feature, pharma
Healthcare is an evolving continuum, and while traditional strategies have seen improvements to patient outcomes over time, voices in the …
Precision cancer treatment for dogs moves towards human testing
January 29, 2019Manufacturing and Production CAR-T therapy, Cancer, Precision Medicine, car t therapy, dogs, t cells, t-cells
Scientists at the University of Missouri have developed a patient specific, precision medicine treatment for bone cancer in dogs. The …
How tech is powering precision treatment
January 7, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Precision Medicine, pharma, tech
As the scientific community eschews scattergun approaches and demand rises for higher-quality, targeted care, Matt Fellows explores how technologies such …
NanoBots: The science of small to dwarf the disease
May 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Precision Medicine, nanorobots, pharma
Anjali Shukla delves into the exciting, miniature world of nanorobotics to explore how the ground-breaking technology promises to change the …
Breakthrough in personalised medicine as cancer vaccine shows results
July 6, 2017Research and Development Precision Medicine, personalised medicine, precision oncology
The old adage that everyone is unique holds a lot of water when it comes to cancer treatment. Research has …
MSD receives first FDA approval based on specific genetic feature
May 24, 2017Research and Development, Sales and Marketing MSD, Precision Medicine, biomarker, keytruda
In a historic first, MSD (known as Merck in North America) has received approval for its immunotherapy treatment Keytruda in …
CRISPR: An up close and personal take on precision medicine
April 6, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CRISR, Precision Medicine
Traditional approaches to patient therapies are increasingly showing their age inefficacy, but a powerful new gene editing technology is making …
IBM and Quest forge precision cancer treatment partnership
October 18, 2016Manufacturing and Production, Medical Communications Cancer, Precision Medicine, Quest, ibm, oncology
IBM has revealed it is to join forces with clinical laboratory service provider Quest Diagnostics in a bid to utilise …
Obama announces acceleration of Precision Medicines Initiative
February 26, 2016Medical Communications, Research and Development Obama, Precision Medicine, cancer moonshot, genomics
A year after Barack Obama announced the $200 million Precision Medicines Initiative (PMI), the US President yesterday outlined the next …
MedImmune and UCSF team up to research RAI treatments
January 13, 2016Research and Development MedImmune, Precision Medicine, University of California San Francisco, autoimmunity
AstraZeneca’s biologics R&D arm MedImmune and the University of California, San Francisco (UCSF) have announced a new research collaboration focused …
Chancellor announces drug R&D funding boost in Catapult expansion
July 14, 2015Research and Development Cambridge, Catapults, Chancellor, George Osborne, Northern Powerhouse, Precision Medicine, R&D, UK, alderley, economy
Chancellor George Osborne is giving UK drug R&D a £5 million vote of confidence, after promising new investment into two …
AstraZeneca makes a move into precision medicine
May 13, 2015Research and Development, Sales and Marketing AstraZeneca, Precision Medicine, cardiovascular diseases, diabetes, mhi
AstraZeneca has signalled its intention to ramp up the use of personalised medicine strategies to find new candidate drugs and …
